Gentherm is a global leader with decades of expertise in advanced thermal management, pneumatic comfort technologies and fluid systems. The company's announced combination with Modine Performance Technologies, expected to close by year-end, will position it as a truly differentiated supplier with a stronger product portfolio, broader end-market diversification, and an enhanced platform for profitable growth.
Cyborg Score Rationale
Gentherm reported record Q3 2025 revenue and announced a transformational combination with Modine Performance Technologies plus an FDA submission for ThermAffyx, though showing mixed stock trading reactions on generally constructive news. Growth trajectory and strategic positioning are solid despite valuation headwinds.
Secured Automotive New Business Awards totaling $485 million in Q4 2025
Launching integrated patient warming and securement system, shifting exposure towards attractive end markets with initial revenue expected in 2026
Climate Control Seat technology available on more than 50 vehicles from major OEMs including Ford, GM, Toyota, Kia, Hyundai, Nissan, Range Rover and Jaguar Land Rover